|
|
Volumn 332, Issue 7535, 2006, Pages 223-224
|
|
Medical treatment of early breast cancer. IV: Neoadjuvant treatment
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANASTROZOLE;
AROMATASE INHIBITOR;
CYCLOPHOSPHAMIDE;
DOCETAXEL;
DOXORUBICIN;
EPIDERMAL GROWTH FACTOR RECEPTOR;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
EXEMESTANE;
LETROZOLE;
TAMOXIFEN;
TRASTUZUMAB;
ARTICLE;
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER STAGING;
CANCER SURVIVAL;
CLINICAL TRIAL;
DRUG EFFICACY;
EARLY CANCER;
HUMAN;
LONG TERM CARE;
MASTECTOMY;
PATIENT SELECTION;
POSTMENOPAUSE;
PREDICTION;
PREOPERATIVE CARE;
PRIORITY JOURNAL;
PROGNOSIS;
STATISTICAL SIGNIFICANCE;
TREATMENT OUTCOME;
|
|
EID: 31644441943
PISSN: 09598146
EISSN: None
Source Type: Journal
DOI: 10.1136/bmj.332.7535.223 Document Type: Article |
|
Times cited : (14)
|
|
References (0)
|
